Philip Bourne and Michael Gribskov of the San Diego Supercomputer Center at the University of California, San Diego have been elected president and vice president, respectively, of the International Society for Computational Biology. Bourne is a professor in the department of pharmacology at UCSD, Gribskov is an adjunct assistant professor of biology at UCSD.
“I believe our election recognizes UCSD''''s and SDSC''''s leadership role in computational biology," Bourne said in a statement. “We have defined a platform that will take the society to a new level of professionalism and hence impact our science in new ways. That platform includes establishing a permanent office of the society, establishing regional affiliates and a more active educational program.”
As part of the spin-in of its iBiomatics unit, Cary, NC-based SAS Institute said it has taken on most of the company’s 67 employees. At the management level, Angela Lightfoot, who was director of biomedical informatics at iBiomatics, is now pharmaceutical practice director at SAS North America. Andrew Fagan has become director of clinical software research and development, the position he held at iBiomatics. Laurie Rose, industry marketing director for SAS, will now head worldwide marketing efforts. Russ Wolfinger, director of genomics at SAS, will lead genomic and discovery software research and development.
Diversa of San Diego, Calif., has appointed Mick Noordewier to senior director of bioinformatics. Prior to joining Diversa, Noordewier was head of anti-infection bioinformatics at GlaxoSmithKline.
The company also hired Lisa Moss as senior director of pharmaceutical business development, Bruce Kimmel as director of protein therapeutics, and Geoffrey Hazlewood as director of industrial enzyme products; while it promoted Mervyn Bibb to senior director of small molecule discovery and Mike Lafferty to director of engineering technology.
MDL Information Systems of San Leandro, Calif., has appointed John Galbraith to senior vice president. Galbraith comes to MDL from Accenture in Zurich, where he served as manager for pharmaceutical and medical products.